Home/Filings/4/0001171843-22-006332
4//SEC Filing

Derby Michael 4

Accession 0001171843-22-006332

CIK 0001444192other

Filed

Sep 29, 8:00 PM ET

Accepted

Sep 30, 4:18 PM ET

Size

5.5 KB

Accession

0001171843-22-006332

Insider Transaction Report

Form 4
Period: 2022-09-28
Transactions
  • Award

    Stock Options (Right to Buy)

    2022-09-28+85,00085,000 total
    Exercise: $0.59Exp: 2032-09-28Class A Common Shares (85,000 underlying)
Footnotes (2)
  • [F1]Based on conversion of exercise price of C$0.80 into U.S. dollars based on an exchange rate of C$1.00 = US$0.7321 on the date of grant.
  • [F2]Stock options granted on 09/28/2022 under Acasti Pharma Inc.'s Stock Option Plan and become exercisable evenly and on a quarterly basis over 36 months.

Documents

1 file

Issuer

Acasti Pharma Inc.

CIK 0001444192

Entity typeother

Related Parties

1
  • filerCIK 0001809613

Filing Metadata

Form type
4
Filed
Sep 29, 8:00 PM ET
Accepted
Sep 30, 4:18 PM ET
Size
5.5 KB